Starting Jan. 1, New Hampshire’s Medicaid program will stop covering GLP-1 drugs — Wegovy, Zepbound, and others — for weight loss, the state Department of Health and Human Services told providers in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback